The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

The sector has been a key focus point of the Vision 2030 reform agenda in Saudi Arabia and transport was one of the fastest ...